Velcade Add-on Doesn’t Improve Survival Outcomes in Newly Diagnosed DLBCL, Trial Shows

Home / Blog / Velcade Add-on Doesn’t Improve Survival Outcomes in Newly Diagnosed DLBCL, Trial Shows